Celldex Therapeutics, Inc. (CLDX)
33.84
+0.51
(+1.53%)
USD |
NASDAQ |
Apr 15, 16:00
33.84
0.00 (0.00%)
After-Hours: 20:00
Celldex Therapeutics Research and Development Expense (Annual) : 241.69M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Plus Therapeutics, Inc. | 8.379M |
| Atossa Therapeutics, Inc. | 21.18M |
| Abeona Therapeutics, Inc. | 24.26M |
| Cell Source, Inc. | 1.898M |
| Kiora Pharmaceuticals, Inc. | 3.714M |